Since self-association of insulin into large aggregates represents significant mechanical problems in insulin delivery devices and might cause complications during diabetes treatment, chemical modifications of this protein were elaborated to generate insulin analogues that can resist aggregation. This evidence concerns the gene INS and diabetes mellitus.